Q4 2023 T2 Biosystems Inc Earnings Call Transcript
Good day, everyone, and welcome to the T2 Biosystems preliminary fourth quarter and full year 2023 Results Conference Call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Tripp Taylor, Investor Relations. Sir, the floor is yours.
Thank you, operator, I'd like to remind everyone that comments made by management today and answers to questions will include forward looking statements. Those include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products.
Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these statements, including the risks and uncertainties described in T2 Biosystems' annual report on Form 10 K filed with the SEC on March 31, 2023 and other filings the company makes with the SEC from time to time. The Company undertakes no obligation to publicly
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |